Why the study?
Most of the global cardiovascular disease burden resides in low- and middle-income countries like Indonesia, but little is known regarding cardiovascular health in Indonesia.
High cardiovascular risk is highly prevalent (29.2%) among Indonesian adults aged ≥40 years, but rates of preventive treatment are extremely low (11% for BP lowering, 1% for statins).
Answers are grounded in this paper and cite their sources.
High CVD risk remains prevalent yet undertreated in Indonesia; hypothesis-generating for urban disparities and prevention needs.
BACKGROUND: The brunt of cardiovascular disease (CVD) burden globally now resides within low- and middle-income countries, including Indonesia. However, little is known regarding cardiovascular health in Indonesia. This study aimed to estimate the prevalence of elevated CVD risk in a specific region of Indonesia. METHODS: We conducted full household screening for cardiovascular risk factors among adults aged 40 years and older in 8 villages in Malang District, East Java Province, Indonesia, in 2016-2017. 10-year cardiovascular risk scores were calculated based on the World Health Organization/International Society of Hypertension's region-specific charts that use age, sex, blood pressure, diabetes status and smoking behaviour. RESULTS: Among 22,093 participants, 6,455 (29.2%) had high cardiovascular risk, defined as the presence of coronary heart disease, stroke or other atherosclerotic disease; estimated 10-year CVD risk of ≥ 30%; or estimated 10-year CVD risk between 10% to 29% combined with a systolic blood pressure of > 140 mmHg. The prevalence of high CVD risk was greater in urban (31.6%, CI 30.7-32.5%) than in semi-urban (28.7%, CI 27.3-30.1%) and rural areas (26.2%, CI 25.2-27.2%). Only 11% and 1% of all the respondents with high CVD risk were on blood pressure lowering and statins treatment, respectively. CONCLUSIONS: High cardiovascular risk is common among Indonesian adults aged ≥40 years, and rates of preventive treatment are low. Population-based and clinical approaches to preventing CVD should be a priority in both urban and rural areas.
No takes yet. Share an insight, caveat, or question.
Maharani et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: